|
|
|||||||
|
Advertisement
|
Diastat
Serious side effects of DiastatSerious problems are rare. Respiratory suppression is possible if more than one dose is given, especially if the first dose was near the upper limit of what the patient can tolerate. Caregivers should be alert for signs of problems with breathing (including a marked decrease in the rate of breathing or a change in the color of the skin) and should summon help if necessary. If the seizure has stopped but no breathing can be seen for more than 8 to 10 seconds, they should call emergency medical personnel. Caution is warranted when prescribing Diastat to seniors or patients with liver or kidney dysfunction, because their clearance of Diastat is reduced. Diastat should also be used with caution in patients with respiratory diseases, such as asthma. Following a dosage of Diastat, patients should avoid activities that require coordination or sustained vigilance until they feel alert. On July 10, 2008, an advisory panel was convened by the Food and Drug Administration (FDA) to review data that the FDA had previously collected from drug studies showing an association between many of the antiepileptic drugs (AEDs) and suicidal ideation and behavior, which together are called suicidality. According to the FDA’s Alert, among the patients with epilepsy in these drug studies, 1 out of 1000 people taking the placebo (inactive substance) showed suicidality compared to approximately 3.5 out of 1000 people who took an AED. The FDA advisory panel voted to accept the FDA's data at its meeting on July 10. The FDA has provided the following information for patients, family members, and caregivers at www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm.
We again urge patients and families to contact their doctor before stopping an epilepsy medication because this may possibly lead to seizures and worsening of mood. Reviewed July 2008 by Steven C. Schachter, MD, epilepsy.com Editorial Board. When a patient presents with a serious and/or unexpected adverse reaction from a medication or device, you should consider reporting this event to Medwatch (http://www.fda.gov/medwatch/report/hcp.htm). To download Medwatch reporting forms click here (http://www.fda.gov/medwatch/getforms.htm). |
||||||
|
© 2008 Epilepsy.com/professionals. All rights reserved.
Site Map |
Privacy Statement |
Terms of Use |
Problems? Email webmaster@epilepsytdp.org
|